Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

219,054 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Butyrate Shapes Immune Cell Fate and Function in Allergic Asthma.
Yip W, Hughes MR, Li Y, Cait A, Hirst M, Mohn WW, McNagny KM. Yip W, et al. Among authors: li y. Front Immunol. 2021 Feb 15;12:628453. doi: 10.3389/fimmu.2021.628453. eCollection 2021. Front Immunol. 2021. PMID: 33659009 Free PMC article. Review.
Abortive γδTCR rearrangements suggest ILC2s are derived from T-cell precursors.
Shin SB, Lo BC, Ghaedi M, Scott RW, Li Y, Messing M, Hernaez DC, Cait J, Murakami T, Hughes MR, Leslie KB, Underhill TM, Takei F, McNagny KM. Shin SB, et al. Among authors: li y. Blood Adv. 2020 Nov 10;4(21):5362-5372. doi: 10.1182/bloodadvances.2020002758. Blood Adv. 2020. PMID: 33137203 Free PMC article.
PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin.
Canals Hernaez D, Hughes MR, Dean P, Bergqvist P, Samudio I, Blixt O, Wiedemeyer K, Li Y, Bond C, Cruz E, Köbel M, Gilks B, Roskelley CD, McNagny KM. Canals Hernaez D, et al. Among authors: li y. J Immunother Cancer. 2020 Nov;8(2):e001128. doi: 10.1136/jitc-2020-001128. J Immunother Cancer. 2020. PMID: 33243933 Free PMC article.
Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes.
Messing M, Sekhon MS, Hughes MR, Stukas S, Hoiland RL, Cooper J, Ahmed N, Hamer MS, Li Y, Shin SB, Tung LW, Wellington CL, Sin DD, Leslie KB, McNagny KM. Messing M, et al. Among authors: li y. Front Immunol. 2022 Nov 14;13:1010216. doi: 10.3389/fimmu.2022.1010216. eCollection 2022. Front Immunol. 2022. PMID: 36451808 Free PMC article.
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study.
Ren S, Xiong A, Yu J, Wang X, Han B, Pan Y, Zhao J, Cheng Y, Hu S, Liu T, Li Y, Cheng Y, Feng J, Yi S, Gu S, Gao S, Luo Y, Liu Y, Liu C, Duan H, Wang S, Yang X, Fan J, Zhou C. Ren S, et al. Among authors: li y. Cancer Immunol Immunother. 2024 May 10;73(7):124. doi: 10.1007/s00262-024-03715-4. Cancer Immunol Immunother. 2024. PMID: 38727837 Clinical Trial.
219,054 results
You have reached the last available page of results. Please see the User Guide for more information.